ArticleBMC veterinary research2025
Algae extract supplementation boosts humoral immunity induced by attenuated PRRSV-1 vaccination.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPorcine reproductive and respiratory syndrome (PRRS) remains a major concern for the swine industry worldwide due to its significant economic impact and its association with respiratory co-infections. Vaccination is a key strategy for PRRS control; however, the most effective commercial anti-PRRSV vaccines to date-live attenuated vaccines, also named modified live virus (MLV) vaccines-provide only partial protection. This study investigates whether oral supplementation with formulated Ulva-derived seaweed extracts can enhance immune responses to PRRSV-1 MLV vaccination.
methodsTwo supplementation protocols using commercial seaweed extracts formulated with vitamin A and D (Searup®) were tested: one starting one day post-vaccination for five consecutive days (post-vaccination), and another beginning one day before vaccination and continuing for two days post-vaccination (pre-vaccination). In this exploratory farm-based experimental setting, pigs were divided into six groups: three vaccinated groups (supplemented with seaweed either pre- or post-vaccination or not supplemented), and three non-vaccinated control groups receiving the same supplementation regimes. Serum cytokine levels, PRRSV viral loads, and anti-PRRSV antibody responses were measured to assess immune modulation.
resultsPost-vaccination supplementation had no significant effect on vaccine viral load or humoral response, though a modest reduction in viral persistence was noted at 12 days post-vaccination (dpv). In contrast, pre-vaccination supplementation significantly increased vaccine virus levels at 4 dpv (p = 0.048) and enhanced anti-PRRSV IgG levels (p = 0.029). This protocol also induced an early and sustained decrease in pro-inflammatory cytokines, suggesting an immunomodulatory effect of algal extract supplemented with Vitamins A and D. We present here for the first time, in field conditions and in the target species, significant immune modifications upon realistic oral supplementation with Searup®. These findings are consistent with previous studies demonstrating the potential of pre-vaccination seaweed supplementation as a cost-effective, practical strategy to enhance humoral responses to PRRSV vaccination. Further studies are needed to evaluate its impact on neutralizing antibody production, cellular responses and protection against heterologous field PRRSV strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.